ArticlePublished 1 Nov 2014
Immunohistochemical panel for differentiating renal cell carcinoma with clear and papillary features
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Aim: Renal cell carcinoma (RCC) in which clear cells with papillary architecture is present is a difficult diagnostic challenge. The most common type, clear cell RCC, only rarely has papillary architecture. The second most common one, papillary RCC (PRCC), only rarely contains clear cells. However, two recently described less-common types, clear cell papillary and Xp11 translocation RCC characteristically feature both papillary architecture and cells with clear cytoplasm. Accurate diagnosis has both prognostic and therapeutic implications. This study aims to highlight the helpful cytomorphologic and immunohistochemical (IHC) features of each of these entities to enable reproducible classification. Materials and Methods: Sixty RCC cases with clear cells and papillary architecture were selected and classified according to The International Society of Urological Pathology (ISUP) Vancouver classification of renal neoplasia and graded according to The ISUP grading system for RCC then stained for cytokeratin 7 (CK7), carbonic anhydrase IX (CA IX), α-methylacyl-coenzyme a racemase (AMACR) and transcription factor E3 (TFE3). Results: the characteristic immunoprofile of clear RCC is CK7−, AMACR−, CA IX+ and TFE3−, PRCC is CK7+, AMACR+, CA IX− and TFE3−, while for clear cell PRCC it is CK7+, AMACR−, CA IX+ and TFE3− and lastly Xp11 translocation RCC is CK7−, AMACR+, CAIX- and TFE3+. Conclusions: IHC staining for CA IX, CK7, AMACR and TFE3 comprises a concise panel for distinguishing RCC with papillary and clear pattern.
Keywords
Subjects
Genetics & Molecular BiologyAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Molecular Pathophysiology
- SubjectGenetics & Molecular Biology
- BylineArticles whose byline prints “hanan alshenawy”
